Promoted Companies

Shares of DSKX began to rally this today as high as 30% after they held a conference call to discuss the recently announced agreement to acquire Radiancy, Inc., a leading developer of consumer medical devices and the Neova® dermatological products. It appears investors are beginning to notice the financial value this new deal brings and the future outlook of the company, so if you haven't already, I highly encourage you to listen to today's conference ...read more

Promoter:

Baran Giresunluoglu

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
DSKX	$5,000	UNKNOWN
Max Profit: 2.24 %	Gain at close: Pending

(NASDAQ: DSKX) DS Healthcare Announces Transformative Acquisition of Radiancy, Inc and Neova® Medical Device and Dermatology Businesses COMBINATION CREATES A GLOBAL LEADER OF DISRUPTIVE TECHNOLOGIES WITH INDUSTRY’S MOST DIVERSIFIED PRODUCT PORTFOLIO. TRANSACTION WILL GENERATE OVER $60 MILLION IN ADDITIONAL GROSS SALES WITHIN THE FIRST 12 MONTHS. http://finance.yahoo.com/news/ds-healthcare-announces-transformative-acquisition-143000552.html ...read more

Promoter:

Baran Giresunluoglu

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
DSKX	$5,000	UNKNOWN
Max Profit: 2.24 %	Gain at close: Pending

(NASDAQ: DSKX) – Research Report Company Name: DS Healthcare Group Inc. Stock Symbol: DSKX (02/01/2016) Currently DSKX has a very attractive valuation with high analyst ratings, hedge fund interest, strengthened management team and major upcoming catalyst. DSKX is trading at a 39M market cap while they’re finalizing the WP Group acquisition which is expected to increase the company’s annual revenues to approximately $65 million ...read more

Promoter:

Baran Giresunluoglu

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
DSKX	$5,000	UNKNOWN
Max Profit: 2.24 %	Gain at close: Pending

(NASDAQ: DSKX) – Research Report Company Name: DS Healthcare Group Inc. Stock Symbol: DSKX Trading at $1.77 Per Share (02/01/2016) Currently DSKX has a very attractive valuation with high analyst ratings, hedge fund interest, strengthened management team and major upcoming catalyst. DSKX is trading at a 39M market cap while they are expected to close on a major acquisition which is expected to increase the company’s annual revenues to approximately ...read more

Promoter:

Baran Giresunluoglu

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
DSKX	$5,000	UNKNOWN
Max Profit: 2.24 %	Gain at close: Pending

DSKX Starting To Creep Up !! (NASDAQ: DSKX) – Research Report Company Name: DS Healthcare Group Inc. Stock Symbol: DSKX Trading at $1.77 Per Share (02/01/2016) Currently DSKX has a very attractive valuation with high analyst ratings, hedge fund interest, strengthened management team and major upcoming catalyst. DSKX is trading at a 39M market cap while they are expected to close on a major acquisition which is expected to increase the company’s ...read more

Promoter:

Baran Giresunluoglu

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
DSKX	$5,000	UNKNOWN
Max Profit: 2.24 %	Gain at close: Pending

Last week DSKX made a insane move with highs of $2.17 and popped up on everyone's scanners, Now the stock coming off a nice pullback from its recent highs and its looking very attractive here at these bottom levels especially with the market cap at its lows. With momentum building up and the acquisition coming soon, Its time to turn all our attention back to DSKX I'm one 100 % confident on this one. Stay focused on DSKX especially after seeing how fast ...read more

Promoter:

Baran Giresunluoglu

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
DSKX	$5,000	UNKNOWN
Max Profit: 2.24 %	Gain at close: Pending

(NASDAQ: DSKX) – Research Report Company Name: DS Healthcare Group Inc. Stock Symbol: DSKX Company Website: www.dslaboratories.com Trading at $1.77 Per Share (02/01/2016) Currently DSKX has a very attractive valuation with high analyst ratings, hedge fund interest, strengthened management team and major upcoming catalyst. DSKX is trading at a 39M market cap while they are expected to close on a major acquisition which ...read more

Promoter:

Baran Giresunluoglu

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
DSKX	$5,000	UNKNOWN
Max Profit: 2.24 %	Gain at close: Pending

  You Must Be there! Email not displaying correctly?View it in your browser.   DSKX                     THIRD QUATER FINANCIAL RESULTS HAVE BEEN                               ...read more

Promoter:

Happy Penny Stocks

Paying Party:

Cash Instant

Stocks covered:	Compensation:	Avg $ Volume for Period:
DSKX	$1,500	43,877
Max Profit: 3.75 %	Gain at close: -4.45 %

  Divine Skin Announces Name Change and Reverse Stock Split Reverse Split and Potential Up-listing To Nasdaq Expected to Benefit the Company Through Better Awareness, Access to                            Capital, and Increased Share Liquidity  Miami Beach, Nov. 29, 2012 (GLOBE NEWSWIRE) -- Divine Skin ...read more

Promoter:

Undiscovered Equities.com

Paying Party:

No Third Party

Stocks covered:	Compensation:	Avg $ Volume for Period:
DSKX	Unknown compensation	UNKNOWN
Max Profit: 7.96 %	Gain at close: 4.00 %

    Divine Skin Adds Keith Markey, Ph.D. to Its Board of Directors      Divine Skin Inc., (DSKX) a leading developer and formulator of personal care products, today announced it has added Dr. Keith Markey to its Board of Directors.   Dr. Markey has been a research analyst for Griffin Securities for the past 5 years and has more than 25 years of experience in the financial services ...read more

Promoter:

Undiscovered Equities.com

Paying Party:

No Third Party

Stocks covered:	Compensation:	Avg $ Volume for Period:
DSKX	Unknown compensation	UNKNOWN
Max Profit: 7.96 %	Gain at close: 4.00 %